SynthesisFrontiers in medicine2026

Efficacy and safety of GLP-1 receptor agonists in patients with metabolic-associated fatty liver diseases: an umbrella review.

Hui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.